Iovance Biotherapeutics, Inc.

IOVANASDAQHealthcare● Active

$4.09

$-0.14(-3.31%)

Market Cap$1.5B

P/E Ratio—

52W High$5.63

52W Low$1.66

Avg Volume15.6M

Open$4.29

Beta0.70

Employees Ownership Insider Trades

Iovance Biotherapeutics, Inc. (IOVA) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · IOVA · as of Feb 24, 2026

Latest filing snapshot

975

+137+16.35%vs prior year

Iovance Biotherapeutics, Inc. (IOVA) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

975

Change (1Y)

+137

Growth % (1Y)

+16.35%

Revenue / Employee

$270.3K

Net Income / Employee

$-401.0K

Market Cap

$1.5B

IOVA Employee Count

2008 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-24	2025-12-31	975	+137	+16.35%
2025-02-27	2024-12-31	838	+281	+50.45%
2024-02-28	2023-12-31	557	+54	+10.74%
2023-02-28	2022-12-31	503	+184	+57.68%
2022-02-24	2021-12-31	319	+78	+32.37%
2021-02-25	2020-12-31	241	+93	+62.84%
2020-02-25	2019-12-31	148	+60	+68.18%
2019-02-28	2018-12-31	88	+25	+39.68%
2018-03-12	2017-12-31	63	+12	+23.53%
2017-03-09	2016-12-31	51	+31	+155.00%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

IOVA

Iovance Biotherapeutics, Inc.YOU

975$1.5B #2

DNA

Ginkgo Bioworks Holdings, Inc.

834$537M #3

CTMX

CytomX Therapeutics, Inc.

Astria Therapeutics, Inc.

78$718M #6

AVBP

ArriVent BioPharma, Inc. Common Stock

52$1.4B #7

MBX

MBX Biosciences, Inc. Common Stock

43$954M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · IOVA peer comparison

About IOVA employees

IOVA Employees · Headcount

Iovance Biotherapeutics, Inc. (IOVA) employee data is sourced from the annual SEC 10-K filing. As of 2025, Iovance Biotherapeutics, Inc. had 975 full-time employees globally. Full-time employees only. Global consolidated headcount.

Iovance Biotherapeutics, Inc. employs 975 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $270,258, reflecting the company's operational efficiency.

Iovance Biotherapeutics, Inc.'s workforce increased by 137 (16.35%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Iovance Biotherapeutics, Inc.'s revenue per employee of $270,258 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

IOVA Employees · 5 questions

As of the latest SEC 10-K filing (2025), Iovance Biotherapeutics, Inc. had 975 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Iovance Biotherapeutics, Inc. employee counthow many employees does Iovance Biotherapeutics, Inc. haveIOVA total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-24